Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 13
Phase 22

Trial Status

Completed1
Recruiting3
Other1

Role Distribution

Principal Investigator5
PI Rate100%

Activity Timeline

Clinical Trials (5)

NCT05803018Phase 1/2Recruiting
A Study of BL-B01D1 in Patients With Multiple Solid Tumors, Including Recurrent or Metastatic Gynecological Malignancies
Gynecological Malignant TumorSolid Tumor
PrincipalinvestigatorStart date: 2023-06-25
NCT05631964Phase 1Recruiting
Phase I Clinical Study of BL-M07D1 in Locally Advanced or Metastatic Digestive Tract Tumors and Other Solid Tumors
Locally Advanced or Metastatic Digestive Tract TumorsOther Solid Tumors
PrincipalinvestigatorStart date: 2023-01-05
NCT05337657Phase 1Unknown
A Phase Ib Study of GB491 Plus Letrozole in Patients With Advanced Breast Cancer
Advanced Breast Cancer
PrincipalinvestigatorStart date: 2021-06-02

Research Network

Collaboration Network

13 collaborators·12 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Weijian Guo, PhD

Fudan University

Related
2 trials

Shared therapeutic areas:

Locally Advanced or Metastatic Digestive Tract TumorsOther Solid Tumors

Worked with same sponsors:

Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.Sichuan Baili Pharmaceutical Co., Ltd.+1 more
Collaborated on 1 trial
Similarity Score24%

Xichun Hu, PhD

Fudan University

Related
4 trials

Shared therapeutic areas:

Advanced Breast CancerBreast Cancer

Worked with same sponsors:

Fudan UniversityGenor Biopharma Co., Ltd.
Collaborated on 1 trial
Similarity Score24%

Xiaohua Wu, PhD

Fudan University

Related
2 trials

Shared therapeutic areas:

Solid TumorGynecological Malignant Tumor

Worked with same sponsors:

Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.Sichuan Baili Pharmaceutical Co., Ltd.
Collaborated on 1 trial
Similarity Score24%

Jiong Wu, PhD

Fudan University

Related
2 trials

Shared therapeutic areas:

Breast Cancer

Worked with same sponsors:

Sichuan Baili Pharmaceutical Co., Ltd.
Collaborated on 1 trial
Similarity Score14%

Lin Shen, MD

Peking University Cancer Hospital & Institute

Related
20 trials

Shared therapeutic areas:

Solid TumorBreast Cancer
Similarity Score10%

Zhenfeng Zhang, MD, PhD

Second Affiliated Hospital of Guangzhou Medical University

Related
21 trials

Shared therapeutic areas:

Breast CancerSolid Tumor
Similarity Score10%

Puma

Biotechnology

Related
26 trials

Shared therapeutic areas:

Breast CancerAdvanced Breast Cancer
Similarity Score10%

Lizhi Niu, PhD

Fuda Cancer Hospital

Related
31 trials

Shared therapeutic areas:

Breast Cancer
Similarity Score5%

Dong-Xin Wang, MD, PhD

Peking University First Hospital

Related
74 trials

Shared therapeutic areas:

Breast Cancer
Similarity Score5%

Ali MA Ismail, lecturer

Cairo University

Related
27 trials

Shared therapeutic areas:

Breast Cancer
Similarity Score5%

Publications (0)

No publications found for this investigator.

Clinical Trials (5)

Showing 5 of 5 trials

NCT06042894Phase 2PrincipalInvestigator

A Study of SI-B003 or BL-B01D1+SI-B003 in Patients With Unresectable Locally Advanced or Recurrent Metastatic HER2 Negative Breast Cancer

Breast Cancer
Recruiting
NCT05803018Phase 1/2PrincipalInvestigator

A Study of BL-B01D1 in Patients With Multiple Solid Tumors, Including Recurrent or Metastatic Gynecological Malignancies

Gynecological Malignant TumorSolid Tumor
Recruiting
NCT05631964Phase 1PrincipalInvestigator

Phase I Clinical Study of BL-M07D1 in Locally Advanced or Metastatic Digestive Tract Tumors and Other Solid Tumors

Locally Advanced or Metastatic Digestive Tract TumorsOther Solid Tumors
Recruiting
NCT05337657Phase 1PrincipalInvestigator

A Phase Ib Study of GB491 Plus Letrozole in Patients With Advanced Breast Cancer

Advanced Breast Cancer
Unknown
NCT05510037PrincipalInvestigator

Incidence and Prognostic Significance of HER-2 Status Discordance Between Primary Breast Cancer and Paired Recurrent/Metastatic Lesions

Breast Cancer
Completed

All 5 trials loaded